On this page · 12 sections

Gemtesa

Generic name: vibegron

Last updated August 10, 2026 0 views Reviewed by Melisa Puckey, BPharm
Share

What is Gemtesa?

Gemtesa (vibegron) is a prescription medicine used to treat overactive bladder (OAB) symptoms of urinary urgency, frequency, and urge incontinence in adults, including men with OAB who are taking medicine for benign prostatic hyperplasia (BPH).

Gemtesa works by relaxing the bladder muscle so the bladder can hold more urine, which may reduce the urgency to use the bathroom and decrease the frequency of urinary leaks or wetting accidents.

Gemtesa's generic name is vibegron.

Gemtesa is a once-daily tablet that is swallowed whole with water or may be crushed, mixed with applesauce, and taken immediately with a glass of water. The tablet can be taken with or without food.

Gemtesa is FDA-approved to treat:

  • Overactive bladder symptoms in adults, including symptoms of urinary urgency, frequency, and urinary urge incontinence.
  • Overactive bladder symptoms in men taking medicines for benign prostatic hyperplasia (BPH).

Gemtesa's mechanism of action (MOA) is to bind and activate the β3-adrenergic receptor, to relax the muscles in the wall of the bladder (detrusor muscle), which increases bladder volume.

Gemtesa class of medications is beta-3 agonists, or more specifically, it is a selective human beta-3 adrenergic receptor agonist (β3-AR agonist).

In the 12-week clinical trial called Study 3003 (NCT03492281) used for overactive bladder symptoms, Gemtesa patients had:

  • 2 fewer daily leakage episodes (compared with 1.4 fewer episodes for placebo)
  • 1.8 fewer bathroom visits per day (compared to 1.3 fewer episodes for placebo)
  • 2.7 fewer “need to urinate immediately” episodes (compared to 2 fewer episodes for placebo.

With the Gemtesa coupon, you may pay as little as $0 out-of-pocket for each 90-day supply if you qualify.

The cost for prescription drugs varies depending on your insurance plan and which pharmacy you use. A Gemtesa coupon or Gemtesa Simple Savings Card may help you save money. For more cost information, refer to the Gemtesa Price Guide page, Gemtesa Coupon: Do I qualify and how much can I save? or "Does Gemtesa have a patient assistance program?"

How should I take Gemtesa?

The usual dose of Gemtesa 75mg is one tablet once daily, swallowed whole with a full glass of water.

You may take Gemtesa with or without food.

If you cannot swallow a tablet whole, you may crush the tablet and mix it with 1 tablespoon of applesauce. Swallow the mixture right away with a glass of water. Do not save the mixture for later use.

Use Gemtesa exactly as prescribed by your doctor. Follow all directions on your prescription label and use the medicines exactly as directed. Follow all directions on your prescription label and read all medication guides or instruction sheets.

Warnings

Gemtesa should not be taken if you have hypersensitivity to the active ingredient vibegron or any of the inactive ingredients in this medicine.

Urinary Retention (inability to empty your bladder): Gemtesa may increase the risk of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for the treatment of an overactive bladder. Tell your doctor right away if you are unable to empty your bladder, and if urinary retention develops, discontinue Gemtesa.

Angioedema: This medicine may cause an allergic reaction called angioedema with swelling of the lips, face, tongue, or throat, with or without difficulty breathing, and may be life-threatening. Stop using Gemtesa and get emergency medical help right away if you have symptoms of angioedema or trouble breathing.

Gemtesa is not recommended in patients with:

  • End-stage renal disease with or without hemodialysis
  • Severe hepatic impairment.

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

You should not take Gemtesa if you are allergic to the active ingredient vibegron or any of the inactive ingredients.

To make sure Gemtesa is safe for you, tell your doctor if you have ever had:

  • Trouble emptying your bladder
  • A weak stream of urine
  • Liver disease
  • Kidney disease
  • Take medicine containing digoxin

Tell your doctor if you are pregnant or breastfeeding.

Gemtesa side effects

Common Gemtesa side effects

The most common Gemtesa side effects include nausea (12%), diarrhea (12%), headache (22%), urinary tract infection (6.6%), or cold symptoms (15%) such as stuffy nose, sneezing, and sore throat, which can affect 2% or more of patients taking this medicine.

Other side effects that occurred were dry mouth, constipation, urinary retention, and hot flush, these side effects occurred in 2% or less of patients.

Serious Gemtesa side effects

Get emergency medical help if you have signs of an allergic reaction to Gemtesa with symptoms of hives, difficulty breathing, and swelling of your face, lips, tongue, or throat.

Call your doctor at once if:

  • You are unable to empty your bladder completely.
  • You have pain or burning when you urinate.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Gemtesa Dosing information

Gemtesa dosing information

Usual Adult Gemtesa Dose: One Gemtesa 75 mg tablet orally once a day.

End-stage renal disease with or without hemodialysis: Not recommended

Severe Hepatic impairment: Not recommended.

Strength available

  • Gemtesa 75mg tablet

Missed Dose

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

Overdose

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect Gemtesa?

Tell your doctor about all your other medicines, especially:

  • digoxin or digitalis.

This list is not complete. Other drugs may interact with vibegron, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Storage

Store at 20°C to 25°C (68°F to 77°F).

Manufactured for and Distributed by: Sumitomo Pharma America, Inc., Marlborough, MA 01752.

Ingredients

Active ingredient: vibegron.

Inactive ingredients: Croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, mannitol, and microcrystalline cellulose. The light green film coating contains FD&C Blue No. 2 - aluminum lake, hypromellose, iron oxide yellow, lactose monohydrate, titanium dioxide, and triacetin.

Common questions about Gemtesa

Does Gemtesa (vibegron) cause constipation?
Constipation is listed as a side effect of Gemtesa, but it is uncommon, occurring in less than 2% (2 out of every 100) people who take Gemtesa.
Gemtesa vs Myrbetriq: What’s the difference?
Gemtesa and Myrbetriq are both prescription medicines for overactive bladder that work on the same type of receptor (β3‑adrenergic) but differ in dosing, side‑effect profile, and drug interactions. Understanding these differences can help you and your doctor choose which option may fit you better. Continue reading
Can Gemtesa cause dementia?
Gemtesa (vibegron) is not known to cause dementia or memory loss, and current evidence suggests dementia risk is higher with anticholinergic bladder medicines than with beta‑3 agonists like Gemtesa. Continue reading
How long does it take for Gemtesa (vibegron) to work?
Gemtesa (vibegron) starts working almost immediately – within a few days of first taking it, with noticeable improvements in urinary urgency, frequency, and incontinence noted in clinical trials at 2 weeks which were reported as significant by 12 weeks. After 12 weeks, people taking Gemtesa had 2 fewer daily leakage episodes compared to 1 fewer episode in those taking placebo, 2 fewer bathroom visits (versus 1 fewer with placebo), and 3 fewer “urge to go” visits a day compared to 2 fewer with placebo. Continue reading
Is Gemtesa covered by medicare?
Gemtesa is often covered by Medicare drug plans, but coverage, tier, and out‑of‑pocket cost depend on the specific Part D or Medicare Advantage Prescription Drug (MAPD) plan’s formulary rather than on a single national rule. Continue reading
Does Gemtesa cause high blood pressure?
No, it isn’t common for Gemtesa (vibegron) to cause high blood pressure. In clinical studies of patients taking 75 mg of Gemtesa per day, Gemtesa had rates of high blood pressure that were similar to placebo. Continue reading
What is the best time to take Gemtesa?
There is no single “best” time of day to take Gemtesa. You can take it in the morning, afternoon, or evening, with or without food, exactly as directed by your doctor. The most important thing is to take one dose about the same time every day so it becomes part of your routine and you are less likely to miss it. Continue reading
How does Gemtesa (vibegron) work?
Gemtesa (vibegron) works by relaxing the detrusor muscle of the bladder – this is smooth muscle found in the wall of the bladder – and it does this by activating beta-3 adrenergic receptors located in the detrusor muscle. By activating these receptors, the muscle in the bladder wall relaxes. This allows the bladder to hold more urine, which can relieve symptoms of overactive bladder such as needing to pass urine immediately or frequently (urinary urgency and frequency) and reduce urine leakage (urinary incontinence). Continue reading
Can men take Gemtesa?
Yes, men can take Gemtesa (vibegron) for the treatment of overactive bladder (OAB). Overactive bladder is a condition that causes symptoms of urinary incontinence, urgency, and frequency. Continue reading

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language Source: Drugs.com

Content is provided for education and is not medical advice. See our medical disclaimer. Source page medically reviewed by Melisa Puckey, BPharm on August 10, 2026.